No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

(2019) Daniel A. Nation et al.   NATURE MEDICINE

Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis

(2019) Antoine Leuzy et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Amyloid β deposition in subcortical stroke patients and effects of educational achievement: A pilot study

(2019) Fumihiko Yasuno et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Predictors for Favorable Cognitive Outcome Post-Stroke: A-Seven-Year Follow-Up Study

(2019) Guri Hagberg et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

(2019) Ebba Gløersen Müller et al.   PLoS One

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

(2018) Oskar Hansson et al.   Alzheimers & Dementia

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques

(2018) Milos D. Ikonomovic et al.   Alzheimers Research & Therapy

Longitudinal Effect of Stroke on Cognition: A Systematic Review

(2018) Eugene YH Tang et al.   Journal of the American Heart Association

Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting

(2018) Rosebud O. Roberts et al.   JAMA Neurology

Spreading of Amyloid, Tau, and Microvascular Pathology in Alzheimer's Disease: Findings from Neuropathological and Neuroimaging Studies

(2018) Dietmar Rudolf Thal et al.   JOURNAL OF ALZHEIMERS DISEASE

Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition

(2017) Rebecca F. Gottesman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

(2017) Nicola Logallo et al.   LANCET NEUROLOGY

Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β-amyloid PET brain images

(2017) Christopher J. Buckley et al.   NUCLEAR MEDICINE COMMUNICATIONS

Development and validation of a risk score (CHANGE) for cognitive impairment after ischemic stroke

(2017) Russell J. Chander et al.   Scientific Reports

Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment

(2016) Frank Arne Wollenweber et al.   STROKE

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

(2016) Ronald C. Petersen et al.   JAMA Neurology

Risk factors for incident dementia after stroke and transient ischemic attack

(2015) Jie Yang et al.   Alzheimers & Dementia

Establishment and Dysfunction of the Blood-Brain Barrier

(2015) Zhen Zhao et al.   CELL

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hippocampal Complex Atrophy in Poststroke and Mild Cognitive Impairment

(2015) Per Selnes et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Clearance systems in the brain—implications for Alzheimer disease

(2015) Jenna M. Tarasoff-Conway et al.   Nature Reviews Neurology

Classification of Subtypes of Ischemic Stroke: History of the Trial of Org 10 172 in Acute Stroke Treatment Classification

(2015) H. P. Adams et al.   STROKE

Influence of Amyloid-β on Cognitive Decline After Stroke/Transient Ischemic Attack

(2015) Wenyan Liu et al.   STROKE

Positron Emission Tomographic Imaging in Stroke

(2015) Ramesh Sahathevan et al.   STROKE

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

(2015) Katarzyna Adamczuk et al.   Alzheimers Research & Therapy

Post-stroke cognitive decline: an update and perspectives for clinical research

(2014) M. Brainin et al.   EUROPEAN JOURNAL OF NEUROLOGY

Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads

(2014) L. Thurfjell et al.   JOURNAL OF NUCLEAR MEDICINE

Comorbid Aβ toxicity and stroke: hippocampal atrophy, pathology, and cognitive deficit

(2014) Zareen Amtul et al.   NEUROBIOLOGY OF AGING

Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old

(2014) O. L. Lopez et al.   NEUROLOGY

Amyloid Burden, Neuroinflammation, and Links to Cognitive Decline After Ischemic Stroke

(2014) Alexander Thiel et al.   STROKE

Erratum to “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis”

(2014) Daniela Perani et al.   Biomed Research International

Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42

(2014) Sebastian Palmqvist et al.   JAMA Neurology

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Predictors for cognitive decline in patients with confluent white matter hyperintensities

(2012) Vincent Mok et al.   Alzheimers & Dementia

Incidence and Subtypes of MCI and Dementia 1 Year after First-Ever Stroke in Patients without Pre-Existing Cognitive Impairment

(2012) Hege Ihle-Hansen et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cerebrovascular lesions induce transient  -amyloid deposition

(2011) M. Garcia-Alloza et al.   BRAIN

Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B

(2011) J. H. Lee et al.   NEUROLOGY

Vascular Contributions to Cognitive Impairment and Dementia

(2011) Philip B. Gorelick et al.   STROKE

Pittsburgh compound B binding in poststroke dementia

(2010) Vincent Mok et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

The Role of Apolipoprotein E in Alzheimer's Disease

(2009) Jungsu Kim et al.   NEURON

FAS and CFL Forms of Verbal Fluency Differ in Difficulty: A Meta-analytic Study

(2008) Danielle Barry et al.   APPLIED NEUROPSYCHOLOGY